All those links are nice and good however nothing could be further from the truth.
The focus should be directed at KKR and not LCY.
KKR owns LCY and has no desire to acquire BIOAQ's debt... to include their stock.
The reason why the CUSIP was suspended is because the BK15 might not yet be finalized but close enough for FINRA to wait and see the final paperwork. BIOAQ is no longer active. As you noted in the links, there is no BioAmber only LCY name on the boards.
In most BKs, the CUSIP is revoked as the new one takes its place... however, in this case, there is no "new" CUSIP since LCY nor KKR is buying BioAmber, only it's assets. Stocks are not assets. Keep that in mind.
KKR owns LCY for $1.56 Bil... LCY is not going to go against it's parent. So if KKR doesn't move to acquire BIOAQ, guess what? It falls into never-never land.
It is pretty simple... Too much focus is being placed on the child but not the parent. Look at all your links... especially wikipedia
You did a lot of DD but did not DD the parent company...that is where the focus should be.
Dragon52
